Pharmacology and in Vitro Profiling of a Novel Peroxisome Proliferator-Activated Receptor .GAMMA. Ligand, Cerco-A-Reference-Cited by-同舟云学术

Pharmacology and in Vitro Profiling of a Novel Peroxisome Proliferator-Activated Receptor .GAMMA. Ligand, Cerco-A

Published:2011 Issue:7 Volume:34 Page:1094-1104
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Wakabayashi Kenji¹²³⁴,Hayashi Shinko²,Matsui Yumi³,Matsumoto Takuo²,Furukawa Akihiro³,Kuroha Masanori³,Tanaka Naomi³,Inaba Tomoko³,Kanda Shoichi³,Tanaka Jun³,Okuyama Ryo³,Wakimoto Satoko³,Ogata Tsuneaki³,Araki Kazushi³,Ohsumi Jun³

Affiliation:

1. Graduate School of Life and Environmental Sciences, University of Tsukuba

2. Kasai R&D Center, Daiichi Sankyo Co., Ltd.

3. Shinagawa R&D Center, Daiichi Sankyo Co., Ltd.

4. Bioassesssment Group I, Research Department III, Daiichi Sankyo RD Associe Co., Ltd.

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

http://www.jstage.jst.go.jp/article/bpb/34/7/34_7_1094/_pdf

Reference38 articles.

1. PPARγ: a Nuclear Regulator of Metabolism, Differentiation, and Cell Growth

2. Physiological and Therapeutic Roles of Peroxisome Proliferator-Activated Receptors

3. Nuclear Receptors and Lipid Physiology: Opening the X-Files

4. An Essential Regulator of Adipogenesis and Modulator of Fat Cell Function: PPARγ

5. 5) Evans R. M., Barish G. D., Wang Y. X., Nat. Med., 10, 355—361 (2004).

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel thiazolidin-4-one benzenesulfonamide hybrids as PPARγ agonists: Design, synthesis and in vivo anti-diabetic evaluation;European Journal of Medicinal Chemistry;2024-04

2. Comparative Computational Screening of Natural-based Partial Agonists for PPARγ Receptor;Medicinal Chemistry;2023-07

3. Structural basis of the activation of PPARγ by the plasticizer metabolites MEHP and MINCH;Environment International;2023-03

4. Therapeutic potential of PPARγ natural agonists in liver diseases;Journal of Cellular and Molecular Medicine;2020-02-07

5. Discovery of DS-6930, a potent selective PPARγ modulator. Part II: Lead optimization;Bioorganic & Medicinal Chemistry;2018-10